Latest filing published 30 Apr 2014 for AXIM BIOTECHNOLOGIES, INC..
No signal scores available.
Rosemary Samuels is a declared insider of Axim Biotechnologies, Inc., with filings sourced from SEC (Form 4). The record holds 2 filings, all for trades on 21 March 2014.
Sales make up the whole of the open-market record (2 sales, €290.2M). No amount is published for 1 filing, which the totals therefore leave out.
The newest entry dates from 30 April 2014: an open-market sale, in Axim Biotechnologies, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations